DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM (DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEF) — FDA Approval ANDA205947 (LUP
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM (DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEF) — FDA Approval ANDA205947 (LUP is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM; Active ingredients: DROSPIRENONE; ETHINYL ES
| Brand name | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM |
|---|---|
| Active ingredients | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM |
| Application number | ANDA205947 |
| Sponsor | LUPIN |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20180613 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →